Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study
Jacob Ghotbi,Davit Aghayan,Åsmund Fretland,Bjørn Edwin,Nicholas L. Syn,Federica Cipriani,Mohammed Alzoubi,Chetana Lim,Olivier Scatton,Tran Cong duy Long,Paulo Herman,Fabricio Ferreira Coelho,Marco V. Marino,Vincenzo Mazzaferro,Adrian K.H. Chiow,Iswanto Sucandy,Arpad Ivanecz,Sung-Hoon Choi,Jae Hoon Lee,Mikel Prieto,Marco Vivarelli,Felice Giuliante,Andrea Ruzzenente,Chee-Chien Yong,Constantino Fondevila,Mikhail Efanov,Zenichi Morise,Fabrizio Di Benedetto,Raffaele Brustia,Raffaele Dalla Valle,Ugo Boggi,David Geller,Andrea Belli,Riccardo Memeo,Alejandro Mejia,James O. Park,Fernando Rotellar,Gi-Hong Choi,Ricardo Robles-Campos,Xiaoying Wang,Robert P. Sutcliffe,Johann Pratschke,Chung-Ngai Tang,Charing C.N. Chong,Mathieu D'Hondt,Kazuteru Monden,Santiago Lopez-Ben,T. Peter Kingham,Alessandro Ferrero,Giuseppe Maria Ettorre,Giovanni Battista Levi Sandri,Franco Pascual,Daniel Cherqui,Xiao Liang,Alessandro Mazzotta,Go Wakabayashi,Mariano Giglio,Roberto I. Troisi,Ho-Seong Han,Tan-To Cheung,Atsushi Sugioka,Kuo-Hsin Chen,Rong Liu,Olivier Soubrane,David Fuks,Luca Aldrighetti,Mohammad Abu Hilal,Brian K.P. Goh,Mikel Gastaca,Juul Meurs,Celine De Meyere,Kit-Fai Lee,Kelvin K. Ng,Diana Salimgereeva,Ruslan Alikhanov,Lip-Seng Lee,Jae Young Jang,Yutaro Kato,Masayuki Kojima,Jaime Arthur Pirola Kruger,Victor Lopez-Lopez,Margarida Casellas I Robert,Roberto Montalti,Boram Lee,Mizelle D'Silva,Hao-Ping Wang,Mansour Saleh,Zewei Chen,Shian Yu,Simone Vani,Francesco Ardito,Ugo Giustizieri,Davide Citterio,Federico Mocchegiani,Marco Colasanti,Yoelimar Guzmán,Kevin P. Labadie,Maria Conticchio,Epameinondas Dogeas,Emanuele F. Kauffmann,Mario Giuffrida,Daniele Sommacale,Alexis Laurent,Paolo Magistri,Phan Phuoc Nghia,Kohei Mishima,Bernardo Dalla Valle,Felix Krenzien,Moritz Schmelzle,Prashant Kadam,Qu Liu,Junhao Zheng,Tiing Foong Siow,Fabio Forchino,Mengqiu Yin,Eric C.H. Lai
DOI: https://doi.org/10.1016/j.ejso.2023.01.014
IF: 4.037
2023-01-01
European Journal of Surgical Oncology
Abstract:BACKGROUND: Minimal invasive liver resections are a safe alternative to open surgery. Different scoring systems considering different risks factors have been developed to predict the risks associated with these procedures, especially challenging major liver resections (MLR). However, the impact of neoadjuvant chemotherapy (NAT) on the difficulty of minimally invasive MLRs remains poorly investigated.METHODS: Patients who underwent laparoscopic and robotic MLRs for colorectal liver metastases (CRLM) performed across 57 centers between January 2005 to December 2021 were included in this analysis. Patients who did or did not receive NAT were matched based on 1:1 coarsened exact and 1:2 propensity-score matching. Pre- and post-matching comparisons were performed.RESULTS: In total, the data of 5189 patients were reviewed. Of these, 1411 procedures were performed for CRLM, and 1061 cases met the inclusion criteria. After excluding 27 cases with missing data on NAT, 1034 patients (NAT: n = 641; non-NAT: n = 393) were included. Before matching, baseline characteristics were vastly different. Before matching, the morbidity rate was significantly higher in the NAT-group (33.2% vs. 27.2%, p-value = 0.043). No significant differences were seen in perioperative outcomes after the coarsened exact matching. After the propensity-score matching, statistically significant higher blood loss (mean, 300 (SD 128-596) vs. 250 (SD 100-400) ml, p-value = 0.047) but shorter hospital stay (mean, 6 [4-8] vs. 6 [5-9] days, p-value = 0.043) were found in the NAT-group.CONCLUSION: The current study demonstrated that NAT had minimal impact on the difficulty and outcomes of minimally-invasive MLR for CRLM.
oncology,surgery